Fund research to develop and advance cancer cell and gene therapies that leverage the body’s immune system to control and ultimately eradicate cancer.
Alliance for Cancer Gene Therapy Inc. centers its grantmaking on cell and gene therapy research for cancer, with recent awards ranging from large investigator and research-fellow grants to smaller follow-on research payments. The foundation backs translational work intended to move cancer therapies toward clinical use, and its program list shows repeated attention to solid tumors, pancreatic cancer, breast cancer, gynecologic cancers, pediatric cancers, glioblastoma, and CAR T-cell approaches. Its recent grant history includes major awards to The Children’s Hospital of Philadelphia and St Jude Children’s Research Hospital, along with a $930,284 grant to the University of Pennsylvania Office of Research Services. The presence of both large multi-hundred-thousand-dollar awards and smaller grants points to a structure that supports full research projects as well as continuation funding. The foundation’s active programs also show that it funds academic investigators, collaborative projects, and biotech proposals where the work is aimed at clinical breakthroughs. Across the recent grants list, the funding is concentrated in cancer research rather than general biomedical giving, and the grantee mix includes hospitals, universities, and research centers working on translational cancer science.
The foundation’s most specific program areas are tied to named disease targets. In pediatric cancer research, it gave $1,462,868 to The Children’s Hospital of Philadelphia and $1,446,554 to St Jude Children’s Research Hospital. For translational cancer work beyond a single tumor type, it awarded $500,000 to Mackall Stamford and $500,000 to Chiocca Beckman Rsrch. Pancreatic cancer is another recurring emphasis. The recent grants list includes $480,024 to Fueyo Univ of Texas and $6,483 to the University of Texas MD Anderson Cancer Center, both tagged cancer research. The foundation also supports gynecologic and breast cancer research through active RFAs, including cell and gene therapy work for ovarian, endometrial, cervical, HER2-positive, and triple negative breast cancer. These program names show a consistent focus on translational research that can move into clinical application.
Alliance for Cancer Gene Therapy Inc. gives across a wide spread of award sizes. The reported distribution is p25 of $1,878, a median grant of $12,057, and p75 of $492,904, which reflects a mix of small follow-on payments and larger project awards. Recent grants also show repeated funding to the same institutions over multiple years, including Pci, Zureikat Univ Pitts, Fueyo Univ of Texas, Okada Univ of CA, and Chen Yale Univ. The foundation operates through research programs rather than individual giving, and it does not fund individuals. Its active programs include unsolicited RFAs in several cancer categories, plus fellowships, investigator awards, collaboration awards, and biotech funding. The recent grant list is entirely composed of U.S. recipients.
$2M
$20.2M
$5.2M
$3.1M
Most grants fall between $2K and $493K, with a median of $12K.
25th Percentile
$2K
Median
$12K
75th Percentile
$493K
About 10% of grants go to recipients in PA.
KEVIN HONEYCUTT
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Grantmaking is regional and heavily U.S.-based: 22 of 22 recent grants went to U.S. recipients. Massachusetts is the top state by grant count, and 12% of grants went to recipients in Connecticut. Named recipient cities in the recent list include Philadelphia, Memphis, New York, Redwood City, Somerville, San Francisco, Seattle, Pittsburgh, Houston, and New Haven. Several of the largest awards went to Philadelphia institutions, including The Children’s Hospital of Philadelphia and the University of Pennsylvania Office of Research Services. Other recurring locations include New York and Pittsburgh, alongside multiple awards to California-based grantees.
Its programs focus on cancer cell and gene therapy, with named emphasis on solid tumors, pancreatic cancer, breast cancer, gynecologic cancers, pediatric cancers, glioblastoma, and CAR T-cell and oncolytic virus approaches. The recent grants list is consistent with that research-oriented focus.
Yes. Several active programs are marked as accepting unsolicited requests for applications, including the Research Fellows program, the Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers, the breast cancer investigator award, the pancreatic cancer investigator award, and the gynecologic cancer investigator award.
The reported grant-size distribution is p25 at $1,878, median at $12,057, and p75 at $492,904. That pattern suggests the foundation makes both smaller continuation payments and larger project-level awards.
No. The recent grant list shows repeat support to the same organizations across multiple years, including Pci, Zureikat Univ Pitts, Fueyo Univ of Texas, Okada Univ of CA, and Chen Yale Univ. The active program list also includes multi-year research grants.
Massachusetts is the top state by grant count. Connecticut, the headquarters state, received 12% of grants, while the recent list also includes recipients in Philadelphia, Memphis, New York, Redwood City, Seattle, Pittsburgh, Houston, and New Haven.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UNIVERSITY OF PENNSYLVANIA OFFICE OF RESEARCH SERVICES | PHILADELPHIA, PA | $498,238 | 2026 | CANCER RESEARCH |
| MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $486,965 | 2026 | CANCER RESEARCH |
| YALE UNIVERSITY | NEW HAVEN, CT | $484,725 | 2026 | CANCER RESEARCH |
| ROSWELL PARK CANCER INSTITUTE | BUFFALO, NY | $481,606 | 2026 | CANCER RESEARCH |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL | MEMPHIS, TN | $40,297 | 2026 | CANCER RESEARCH |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | PHILADELPHIA, PA | $31,825 | 2026 | CANCER RESEARCH |
| FRED HUTCHINSON CANCER CENTER | SEATTLE, WA | $13,145 | 2026 | CANCER RESEARCH |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | PHILADELPHIA, PA | $1,462,868 | 2025 | CANCER RESEARCH |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL | MEMPHIS, TN | $1,446,554 | 2025 | CANCER RESEARCH |
| UNIVERSITY OF PENNSYLVANIA OFFICE OF RESEARCH SERVICES | PHILADELPHIA, PA | $930,284 | 2025 | CANCER RESEARCH |
| MACKALL STAMFORD | REDWOOD CITY, CA | $500,000 | 2025 | CANCER RESEARCH |
| CHIOCCA BECKMAN RSRCH | SOMERVILLE, MA | $500,000 | 2025 | CANCER RESEARCH |
| FRED HUTCHINSON CANCER CENTER | SEATTLE, WA | $482,561 | 2025 | CANCER RESEARCH |
| FUEYO UNIV OF TEXAS | HOUSTON, TX | $13,406 | 2025 | CANCER RESEARCH |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | HOUSTON, TX | $6,483 | 2025 | CANCER RESEARCH |
| ZUREIKAT UNIV OF PITTS | PITTSBURGH, PA | $6,009 | 2025 | CANCER RESEARCH |
| OKADA UNIV OF CA | SAN FRAN, CA | $6,008 | 2025 | CANCER RESEARCH |
| PCI | NEW YORK, NY | $750,000 | 2024 | CANCER RESEARCH |
| OKADA UNIV OF CA | SANFRANSICO, CA | $492,904 | 2024 | CANCER RESEARCH |
| FUEYO UNIV OF TEXAS | HOUSTON, TX | $480,024 | 2024 | CANCER RESEARCH |
| ZUREIKAT UNIV PITTS | PITTSBURGH, PA | $12,057 | 2024 | CANCER RESEARCH |
| BROWNICAHN SCHOOL | NEW YORK, NY | $213 | 2024 | CANCER RESEARCH |
| CHEN YALE UNIV | NEW HAVEN, CT | $143 | 2024 | CANCER RESEARCH |
| PCI | NEW YORK, NY | $750,009 | 2023 | CANCER RESEARCH |
| ZUREIKAT U PITTS | PITTSBURGH, PA | $481,942 | 2023 | CANCER RESEARCH |
| FRAIETTE TTEE UPENN | PHILADELPHIA, PA | $1,957 | 2023 | CANCER RESEARCH |
| GOTTSCHALK ST JUDE | MEMPHIS, TN | $1,878 | 2023 | CANCER RESEARCH |
| CHEN YALE UNIV | NEW HAVEN, CT | $891 | 2023 | CANCER RESEARCH |
| BROWNICAHN SCHOOL | NEW YORK, NY | $673 | 2023 | CANCER RESEARCH |
MASSACHUSETTS GENERAL HOSPITAL
$486,965CANCER RESEARCH
CHIOCCA BECKMAN RSRCH
$500,000CANCER RESEARCH
FUEYO UNIV OF TEXAS
$13,406CANCER RESEARCH
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$6,483CANCER RESEARCH
OKADA UNIV OF CA
$6,008CANCER RESEARCH
OKADA UNIV OF CA
$492,904CANCER RESEARCH
FUEYO UNIV OF TEXAS
$480,024CANCER RESEARCH